Dashboard
Manage Tickers

GPCRStructure Therapeutics Inc.

Nasdaq structuretx.com


$ 56.15 $ 2.01 (3.7 %)    

Wednesday, 05-Jun-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 454.82 $ 9.16 (2.02 %)
DIA $ 398.57 $ 1.02 (0.26 %)
SPY $ 530.36 $ 6.28 (1.19 %)
TLT $ 91.26 $ 0.68 (0.73 %)
GLD $ 225.37 $ 2.55 (1.18 %)
$ 56.3
$ 54.61
$ 0.00 x 0
$ 0.00 x 0
$ 51.61 - $ 57.60
$ 25.57 - $ 75.02
2,433,602
na
7.87B
$ 1.07
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 03-08-2024 12-31-2023 10-K
3 11-17-2023 09-30-2023 10-Q
4 08-10-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-30-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

structure-therapeutics-files-registration-statement-for-proposed-public-offering-of-8m-adss
Structure Therapeutics Files Registration ...
06/03/2024 20:10:31

structure-therapeutics-obesity-candidate-is-very-competitive-to-eli-lillys-orforglipron-analyst-says
Structure Therapeutics Obesity Candidate I...
06/03/2024 19:14:17

Structure Therapeutics reports positive 12-week Phase 2a obesity study results for GSBR-1290, showing a 6.2% weight loss. Canto...

why-science-applications-international-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Science Applications International Sha...
06/03/2024 17:56:53

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
06/03/2024 17:35:22

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/03/2024 16:31:06

obesity-data-from-structure-therapeutics-shows-potential-for-weight-loss-drug-candidate
Obesity Data From Structure Therapeutics S...
06/03/2024 15:11:35

Structure Therapeutics announces Phase 2a results for GSBR-1290, showing significant weight loss in obesity study.

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/03/2024 14:48:40

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday
Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
06/03/2024 12:07:05

structure-therapeutics-reports-12-week-results-for-obesity-drug-gsbr-1290-achieving-significant-weight-loss
Structure Therapeutics Reports 12-Week Res...
06/03/2024 11:32:18

Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecu...

this-biotech-stock-is-poised-for-80-upside-with-breakthrough-in-obesity-drug-market-says-jpmorgan
This Biotech Stock Is Poised For 80% Upsid...
05/22/2024 02:41:37

The Structure Therapeutics stock has been identified as a potential winner in the obesity drug market. JPMorgan has given the s...

jp-morgan-initiates-coverage-on-structure-therapeutics-with-overweight-rating-announces-price-target-of-65
JP Morgan Initiates Coverage On Structure ...
05/21/2024 15:55:30

JP Morgan analyst Hardik Parikh initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Overweight rating and anno...

jmp-securities-reiterates-market-outperform-on-structure-therapeutics-maintains-91-price-target
JMP Securities Reiterates Market Outperfor...
05/10/2024 16:50:39

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

structure-therapeutics-q1-eps-019-beats-021-estimate
Structure Therapeutics Q1 EPS $(0.19) Beat...
05/09/2024 22:41:34

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate o...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/03/2024 15:22:18

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-reiterates-overweight-on-structure-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
04/18/2024 13:53:16

Cantor Fitzgerald analyst Prakhar Agrawal reiterates Structure Therapeutics (NASDAQ:GPCR) with a Overweight and maintains $6...

cantor-fitzgerald-initiates-coverage-on-structure-therapeutics-with-overweight-rating-announces-price-target-of-65
Cantor Fitzgerald Initiates Coverage On St...
04/09/2024 11:03:21

Cantor Fitzgerald analyst Prakhar Agrawal initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Overweight ratin...

jmp-securities-reiterates-market-outperform-on-structure-therapeutics-maintains-91-price-target
JMP Securities Reiterates Market Outperfor...
03/08/2024 18:02:55

JMP Securities analyst Jonathan Wolleben reiterates Structure Therapeutics (NASDAQ:GPCR) with a Market Outperform and mainta...

structure-therapeutics-reports-year-end-cash-balance-of-4673m
Structure Therapeutics Reports Year-End Ca...
03/08/2024 13:41:32

12-health-care-stocks-moving-in-tuesdays-pre-market-session
12 Health Care Stocks Moving In Tuesday's ...
12/19/2023 13:07:32

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION